327
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

A Retrospective Study of Ensartinib-Treated ALK-Positive Locally Advanced or Metastatic NSCLC Patients in China

, , , , , , , , & show all
Article: LMT61 | Received 30 May 2023, Accepted 27 Sep 2023, Published online: 07 Nov 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.